Protocol Summaries: eszopiclone
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| ESZ111503 | Phase 3 | A randomised, double-blind, double-dummy, placebo-controlled, 3-way crossover study to evaluate potential next-day residual effects of a single evening dose of 3mg eszopiclone and 7.5mg zopiclone in healthy adult subjects. | Completed |